BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7242308)

  • 1. [Nitrite and methemoglobin formation in dogs following oral isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate].
    Strein K; Dietmann K; Bartsch W
    Med Welt; 1981 Apr; 32(14A):499-502. PubMed ID: 7242308
    [No Abstract]   [Full Text] [Related]  

  • 2. Differences in the nitrite ion formation and the toxicological findings between isosorbide dinitrate and isosorbide-5-mononitrate.
    Strein K; Bartsch W; Sponer G; Müller-Beckmann B; Lexa P
    Toxicol Appl Pharmacol; 1984 Jan; 72(1):142-7. PubMed ID: 6710480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of isosorbide dinitrate, isosorbide-5-mononitrate and sodium nitrite in isolated vascular preparations].
    Heeg E; Langner A
    Med Welt; 1981 Apr; 32(14A):497-8. PubMed ID: 7242307
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of isosorbide-5-mononitrate and isosorbide-2-mononitrate on the contractile and electrical activity and on the content of cyclic nucleotides in isolated heart muscles of the guinea-pig and dog.
    Atanassova R; Spassov G; Balansky R; Boev K
    J Pharm Pharmacol; 1992 Aug; 44(8):663-6. PubMed ID: 1359091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics, effect and tolerance of isosorbide dinitrate and isosorbide-5-mononitrate in healthy persons].
    Abshagen U; Spörl-Radun S; Betzien G; Kaufmann B; Endele R
    Med Welt; 1981 Apr; 32(14A):508-16. PubMed ID: 7242310
    [No Abstract]   [Full Text] [Related]  

  • 6. Early administration of isosorbide dinitrate improves survival of cyanide-poisoned rabbits.
    Lavon O
    Clin Toxicol (Phila); 2015 Jan; 53(1):22-7. PubMed ID: 25519879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Isosorbide-5-mononitrate. A metabolite of isosorbide dinitrate].
    Aldershvile J; Abildgaard U
    Ugeskr Laeger; 1985 Jun; 147(24):1948-9. PubMed ID: 4024344
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
    Strein K; Sponer G; Bartsch W; Müller-Beckmann B; Dietmann K
    J Pharmacol Exp Ther; 1984 Jun; 229(3):787-92. PubMed ID: 6726657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the production of methemoglobin during high-dose treatment with isosorbide dinitrate or isosorbide 5-mononitrate.
    Schneider W; Stahl B; Kaltenbach M; Bussmann WD
    Arzneimittelforschung; 1984; 34(12):1779-82. PubMed ID: 6543314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative pharmacokinetics and bioavailability of isosorbide dinitrate and its metabolites isosorbide 5- and 2-mononitrate from delayed-release preparations].
    Geigenberger A; Degen J; Maier-Lenz H
    Arzneimittelforschung; 1982; 32(9):1138-40. PubMed ID: 6890839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of isosorbide dinitrate and mononitrates after acute and chronic oral administration of isosorbide dinitrate in man.
    Bruyneel K; Rosseel MT; Bogaert MG
    Arzneimittelforschung; 1982; 32(7):769-73. PubMed ID: 6889879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
    Sponer G; Kühnle HF; Strein K; Bartsch W; Endele R; Dietmann K
    J Pharmacol Exp Ther; 1984 Jan; 228(1):235-9. PubMed ID: 6694105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the two mononitrate metabolites of isosorbide dinitrate in human plasma and urine by gas chromatography with electron-capture detection.
    Sioufi A; Pommier F
    J Chromatogr; 1984 Jan; 305(1):95-103. PubMed ID: 6707157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New isosorbide 5-mononitrate derivative with hypotensive activity.
    Coppi G; Borella F; Gatti MT; Comini A; Dall' Asta L
    Boll Chim Farm; 1989 Feb; 128(2):74-6. PubMed ID: 2775521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of human aldehyde dehydrogenase by isosorbide dinitrate.
    Mukerjee N; Pietruszko R
    J Biol Chem; 1994 Aug; 269(34):21664-9. PubMed ID: 8063809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Left ventricular function parameters following administration of isosorbide-5-mononitrate].
    Bergbauer M
    Med Welt; 1983 Jun; 34(22):642-4. PubMed ID: 6877071
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat].
    Leitold M; Laufen H
    Arzneimittelforschung; 1983; 33(8):1117-21. PubMed ID: 6685489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of isosorbide dinitrate and mononitrates in patients with renal failure.
    Bogaert MG; Rosseel MT; Boelaert J; Daneels R
    Eur J Clin Pharmacol; 1981; 21(1):73-6. PubMed ID: 7333349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs].
    Kogi K; Tanaka O; Kimura T; Saito T
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.